NXPH4 and invasive breast carcinoma: NXPH4 levels were observed in the initial stages of Breast invasive carcinoma (BRCA), Cervical squamous cell carcinoma and cervical adenoma (CESC), COAD, and Liver hepatocellular carcinoma (LIHC), and its expression increased significantly as pathological and clinical stages progressed (Figure 1B).